Results 111 to 120 of about 65,767 (202)

A prospective, phase II, neoadjuvant study based on chemotherapy sensitivity in HR+/HER2‐ breast cancer‐FINEST study

open access: yesCancer Communications, Volume 45, Issue 4, Page 411-421, April 2025.
Abstract Background Hormone receptor‐positive (HR+)/humaal growth factor receptor 2‐negative (HER2‐) breast cancer, the most common breast cancer type, has variable prognosis and high recurrence risk. Neoadjuvant therapy is recommended for median‐high risk HR+/HER2‐ patients.
Li Chen   +10 more
wiley   +1 more source

Artificial Intelligence and Breast Cancer Management: From Data to the Clinic

open access: yesCancer Innovation, Volume 4, Issue 2, April 2025.
Artificial intelligence plays an increasingly pivotal role in the diagnosis, treatment, and prognosis assessment of breast cancer. This paper elucidates the fundamental principles of artificial intelligence and delves into its application in breast cancer research while addressing the formidable challenges it encounters in real‐world clinical practice.
Kaixiang Feng, Zongbi Yi, Binghe Xu
wiley   +1 more source

Performance of a Logistic Regression Model Using Paired miRNAs to Stratify Abnormal Mammograms for Benign Breast Lesions

open access: yesCancer Medicine, Volume 14, Issue 8, April 2025.
ABSTRACT Background Mammography is effective in reducing breast cancer mortality, but it has false positive results that cause subsequent interventions such as biopsy or interval repeat mammography. Thus, there is a clinical unmet need for accurate molecular classifiers that can reduce unnecessary additional imaging and/or invasive diagnostic ...
Hideo Akiyama   +9 more
wiley   +1 more source

Inequalities in Fertility‐Impacting Cancer Incidence Among Young Populations in the United States

open access: yesCancer Medicine, Volume 14, Issue 7, April 2025.
ABSTRACT Introduction Infertility is a concerning late effect of cancer and cancer treatments, yet referrals for fertility preservation are unequal across U.S. sociodemographic groups. Although all‐site cancer incidence varies across U.S. sociodemographic groups, it is unclear whether fertility‐impacting cancers, specifically, are unevenly distributed ...
Katherine I. Tierney   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy